Search Within

Radiation Oncology, Department of

Formats
  1. Journal Article (2433)
  2. Meeting Abstract (2044)
  3. Book Section (299)
  4. Review (186)
  5. Editorial (106)
  6. Correspondence (73)
  7. Guidelines (63)
  8. Research Letter (34)
  9. Conference Paper (31)
  10. Book Whole (8)
  11. Miscellaneous (7)
Groups
  1. Survivorship Research (2238)
  2. Department of Medicine (1589)
  3. Surgery (1350)
  4. Solid Tumor Oncology Division (1188)
  5. Medical Physics (940)
  6. GSK Faculty (924)

More Groups

People
  1. Nancy Lee (896)
  2. Joachim Yahalom (635)
  3. Suzanne Wolden (566)
  4. Yoshiya Yamada (480)
  5. Nadeem Riaz (423)
  6. Abraham Wu (405)

More People

Years
  1. 2026 (1)
  2. 2025 (259)
  3. 2024 (411)
  4. 2023 (365)
  5. 2022 (371)
  6. 2021 (359)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (1494)
  2. Journal of Clinical Oncology (404)
  3. Medical Physics (135)
  4. Radiotherapy and Oncology (128)
  5. Blood (118)
  6. Gynecologic Oncology (110)

More Publications

Publishers
  1. Elsevier Inc. (2047)
  2. American Society of Clinical Oncology (434)
  3. Springer (217)
  4. Wiley Blackwell (194)
  5. Lippincott Williams & Wilkins (188)
  6. Oxford University Press (182)

More Publishers

Results (5284)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Partial breast irradiation: An updated consensus statement from the American Brachytherapy Society
    Review

    Anderson, B.; Arthur, D.; Hannoun-Levi, J. M.; Kamrava, M.; Khan, A.; Kuske, R.; Scanderbeg, D.; Shah, C.; Shaitelman, S.; Showalter, T.; more...
    Brachytherapy (2022)

    Fulltext@MSK | Save
  • A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
    Journal Article

    Gunther, J. R.; Chadha, A. S.; Guha, S.; Raju, G. S.; Maru, D. M.; Munsell, M. F.; Jiang, Y.; Yang, P.; Felix, E.; Clemons, M.; more...
    Journal of Gastrointestinal Oncology (2022)

    Fulltext@MSK | Save
  • A simulation study of tolerance of breathing amplitude variations in radiotherapy of lung cancer using 4DCT and time-resolved 4DMRI
    Journal Article

    Li, G.; Sehovic, A.; Xu, L.; Shukla, P.; Zhang, L.; Zhou, Y.; Wang, P.; Wu, A.; Rimner, A.; Zhang, P.
    Journal of Clinical Medicine (2022)

    Fulltext@MSK | Save
  • Permanent carrier-embedded Cesium-131 brachytherapy for the salvage treatment of previously irradiated, recurrent brain metastases
    Meeting Abstract

    Imber, B.; Beal, K.; Reiner, A.; Giantini-Larsen, A.; Yang, J.; Aramburu-Nunez, D.; Cohen, G.; Brennan, C.; Tabar, V.; Young, R.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Identifying patterns of failure after initial therapy in primary CNS lymphoma in a large patient cohort
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Vachha, B.; Schaff, L.; Grommes, C.; Imber, B.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Focused ultrasound mediated blood-brain barrier penetrance to enable cell-free DNA (cfDNA) as a liquid biopsy in recurrent primary brain tumors
    Meeting Abstract

    Miller, A.; Ramamurthy, B.; Pike, L.; Keralapura, M.; Hofius, J.; Marshall, J.; Jones, M.; Lee, C. Y.; Stember, J.; Brennan, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Rising utilization and reduced Medicare spending of short-course radiation therapy for primary CNS tumors in elderly adults
    Meeting Abstract

    Tringale, K.; Miller, A.; Beal, K.; Yang, J.; Pike, L.; Imber, B.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • A macrophage-activated abscopal effect
    Editorial

    Barker, C. A.; Riaz, N.
    Nature Cancer (2022)

    Fulltext@MSK | Save